Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
10/26/1994 | EP0621285A1 Novel megakaryocyte amplifier |
10/26/1994 | EP0621284A1 PEPTIDES CONTAINING RESPECTIVE AMINO ACID SEQUENCES SELECTED FROM AMONG THOSE OF LIPOPROTEIN(a) AND APOLIPOPROTEIN(a), ANTIBODIES RESPECTIVELY RECOGNIZING THESE AMINO ACID SEQUENCES, AND METHOD OF ASSAYING WITH THESE ANTIBODIES |
10/26/1994 | EP0621039A1 Keyhole limpet hemocyanin composition with enhanced anti-tumor activity against bladder cancer |
10/26/1994 | EP0620860A1 Preparation of recombinant borrelia proteins |
10/26/1994 | EP0620855A1 Regulation of plant genes |
10/26/1994 | EP0620854A1 Expression and purification of recombinant soluble tissue factor |
10/26/1994 | EP0620852A1 Cyclic di-guanylate metabolic enzymes |
10/26/1994 | EP0620851A1 Neuroblastoma-associated regulator gene. |
10/26/1994 | EP0620850A1 Immunogenic detoxified mutants of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines |
10/26/1994 | EP0620849A1 Transgenic animal models for alzheimer's disease |
10/26/1994 | EP0620826A1 Tie, a novel endothelial cell receptor tyrosine kinase |
10/26/1994 | EP0620825A1 Heparin- and sulfatide-binding peptides from the type i repeats of human thrombospondin |
10/26/1994 | EP0620741A1 Cytotoxic drug therapy |
10/26/1994 | EP0620740A1 Injectable lecithin gel |
10/26/1994 | EP0620739A1 Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
10/26/1994 | EP0620709A1 Process for isolating lactoferrin and lactoperoxidase from milk and milk products, and products obtained by such process. |
10/26/1994 | EP0431042B1 A method of preparing an active human neutrophil chemotactic factor polypeptide |
10/26/1994 | EP0174366B1 T-cell receptor-specific for antigen polypeptides and related polynucleotides |
10/26/1994 | CN1094093A Progenitor B cell stinulating factor |
10/26/1994 | CN1094092A Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
10/26/1994 | CN1094059A Insulin analogs |
10/25/1994 | US5359135 Detection in soil, water, air by preferential affinity to monoclonal antibodies |
10/25/1994 | US5359120 Improvements relating to the production of prodrugs |
10/25/1994 | US5359051 Compounds useful in the synthesis of nucleic acids capable of cleaning RNA |
10/25/1994 | US5359048 Insecticidal protein from bacillus cultures |
10/25/1994 | US5359047 Nucleic acids encoding DNA structure-specific recognition protein and uses therefor |
10/25/1994 | US5359046 Chimeric chains for receptor-associated signal transduction pathways |
10/25/1994 | US5359039 Isolated poxvirus A53R-equivalent tumor necrosis factor antagonists |
10/25/1994 | US5359037 Antibodies to TNF binding protein I |
10/25/1994 | US5359036 Growth hormone-like glycoproteins |
10/25/1994 | US5359035 Stable antitumor agents |
10/25/1994 | US5359034 Cysteine depleted IL-6 muteins |
10/25/1994 | US5359033 Cleaved dimers of mullerian inhibiting substance-like polypeptides |
10/25/1994 | US5359032 Interkeukin-1 inhibitor |
10/25/1994 | US5359030 Coupling of a peptide and polymer; therapy, diagnosis |
10/25/1994 | US5359029 Having an amine and a carboxy end group(or substituent) which improve binding or immunogenic or antigenic activity and do not change its immunoreactivity |
10/25/1994 | US5358935 Nonantigenic keratinous protein material |
10/25/1994 | US5358931 Interaction of thermal hysteresis proteins with cells and cell membranes and associated applications |
10/25/1994 | US5358868 Strain of Bordetella; production of vaccine |
10/25/1994 | US5358867 DNA cloning and expression of an L7 protein which modulates the 2'-5' oligosynthetase and H2-K*K response to type-I interferon |
10/25/1994 | US5358858 Process for preparing phycoerythrin from bangia atropurpurea and porphyra angusta |
10/25/1994 | US5358857 Method of preparing fusion proteins |
10/25/1994 | US5358853 Liquid thromboplastin reagent |
10/25/1994 | US5358851 Polyclonal antibody from immunizing an animal with immunogenic carrier protein conjugated to p-tolylacetic acid, then binding product to the aromatic ring of benzene or naphthalene derivatives for detection |
10/25/1994 | US5358722 Ferritin analogs |
10/25/1994 | US5358707 Oxidized variants of GM-CSF |
10/25/1994 | US5358649 Diagnosis for porcine malignant hyperthermia |
10/25/1994 | CA1332712C Intravenous pharmaceutical composition |
10/23/1994 | CA2121096A1 Monoclonal antibodies to bovine cytokines |
10/21/1994 | CA2116261A1 Epitopic regions of pneumococcal surface protein a |
10/20/1994 | CA2121296A1 Keyhole limpet hemocyanin composition with enhanced anti-tumor activity against bladder cancer |
10/19/1994 | EP0620282A1 Method of extracting, amplifying and detecting a nucleic acid from whole blood |
10/19/1994 | EP0620281A2 Oilseed crops producing valuable seeds having altered amino acid composition and fatty acid composition |
10/19/1994 | EP0620277A1 Nucleic acid pharmaceuticals |
10/19/1994 | EP0620276A1 Humanised antibodies |
10/19/1994 | EP0620275A1 A bovine group I phospholipase A2 receptor |
10/19/1994 | EP0620231A1 Human parvovirus B19 epitope-related peptide |
10/19/1994 | EP0620010A1 HIV related peptides |
10/19/1994 | EP0620009A1 HIV related peptides |
10/19/1994 | EP0620008A1 Use of vip, analogues and fragments thereof for the treatment of neurodegenerative diseases |
10/19/1994 | EP0619843A1 Icams immunoglobulin constant region soluble fusion proteins |
10/19/1994 | EP0619842A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors |
10/19/1994 | EP0619841A1 T-cadherin adhesion molecule |
10/19/1994 | EP0619840A1 Pseudorabies virus vaccine |
10/19/1994 | EP0619839A1 Novel polypeptides for promoting cell attachment |
10/19/1994 | EP0619836A1 Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments |
10/19/1994 | EP0619824A1 Trophoblast interferons and their use |
10/19/1994 | EP0619823A1 Peptide compounds having therapeutic activity |
10/19/1994 | EP0619742A1 Transfection of lung via aerosolized transgene delivery |
10/19/1994 | EP0619740A1 Polyanionic polyamino acid inhibitors of mineral deposition and their synthesis |
10/19/1994 | EP0619738A1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
10/19/1994 | EP0619736A1 Antiparasitic oligonucleotides active against drug resistant malaria |
10/19/1994 | EP0619732A1 Biodegradable polymers for cell transplantation |
10/19/1994 | EP0590004A4 Purified chitinases and use thereof. |
10/19/1994 | EP0556271B1 Biological active material covalently immobilized on to azlactone-functional polymeric supports and method for preparing it |
10/19/1994 | EP0546084A4 Proteases causing abnormal degradation of amyloid -g(b)-protein precursor |
10/19/1994 | EP0515536A4 Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules |
10/19/1994 | EP0489033B1 Bovine coronavirus polypeptides and vaccines |
10/19/1994 | EP0471701B1 Novel tnf-inhibit proteins and their preparation |
10/19/1994 | CN1093751A Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof |
10/18/1994 | US5357044 Suppressed bactericidal activity |
10/18/1994 | US5357042 Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity |
10/18/1994 | US5357041 Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin |
10/18/1994 | US5356888 1,1-dioxo-cephem-4-carbothiolic acid derivatives |
10/18/1994 | US5356878 Gel filtration of factor VIII |
10/18/1994 | US5356877 Methods for promoting growth using porcine growth hormone analogs |
10/18/1994 | US5356875 Anti-thrombin polypeptides and pharmaceutical compositions thereof |
10/18/1994 | US5356874 Angiogenic factor isolated from live yeast cell derivatives and its use in treating wounds or burns in mammals |
10/18/1994 | US5356816 Method and compositions using polypeptides of arabidopsis thaliana |
10/18/1994 | US5356806 Immortalized human cell lines containing exogenous cytochrome P450 |
10/18/1994 | US5356801 From Rhodococcus rhodochrous |
10/18/1994 | US5356799 Antisense gene systems of pollination control for hybrid seed production |
10/18/1994 | US5356798 Adding egg yolk free of lipoproteins and lipids to increase expression of proteins |
10/18/1994 | US5356797 Membrane expression of heterologous genes |
10/18/1994 | US5356796 Repressor protein and operon for regulating expression of polypeptides and its use in the preparation of 2,2-dialkyglycine decarboxylase of Pseudomonas cepacia |
10/18/1994 | US5356795 Cloning cDNAs for the human interleukin-2 receptor (55 RD protein) |
10/18/1994 | US5356794 Purified enzymatic preparation derived from chromobacterium violaceum, method for preparing it and its use in the production of α, β-dehydrotryptophanyl-peptides |
10/18/1994 | US5356788 Hydrolusis, liquid chromatographic analysis of Bacillus protoxins |
10/18/1994 | US5356783 Inhibitor of tissue factor activity |
10/18/1994 | US5356779 Assay for direct binding of peptides that are T-cell epitopes to MHC gene products on intact antigen-presenting cells and the use thereof for screening susceptibility of autoimmune diseases |